John A Harvin1, Van Thi Thanh Truong, Charles E Green, LaDonna Allen, Jason Murry, John J Radosevich, James N Bogert, Patrick B Murphy, Brandy B Padilla-Jones, Ben L Zarzaur, John R Taylor, Kevin W Sexton, Cassandra Decker, Thomas J Schroeppel, Charles E Wade, Lillian S Kao. 1. From the Department of Surgery and the Center for Translational Injury Research (J.A.H., V.T.T.T., C.E.G., C.E.W., L.S.K.), McGovern Medical School, University of Texas, Houston, Texas; Department of Surgery (L.A., J.M.), University of Texas Health Tyler, Tyler, Texas; Department of Surgery (J.J.R., J.N.B.), St. Joseph's Hospital and Medical Center, Phoenix, Arizona; Department of Surgery (P.B.M., B.B.P.-J., B.L.Z.), Indiana University, Indianapolis, Indiana; Department of Surgery (J.R.T., K.WS.), University of Arkansas for Medical Sciences, Little Rock, Arkansas; and Department of Surgery (C.D., T.J.S.), University of Colorado Health Memorial Hospital Central, Colorado Springs, Colorado.
Abstract
BACKGROUND: Efforts to reduce opioid use in trauma patients are currently hampered by an incomplete understanding of the baseline opioid exposure and variation in United States. The purpose of this project was to obtain a global estimate of opioid exposure following injury and to quantify the variability of opioid exposure between and within United States trauma centers. STUDY DESIGN: Prospective observational study was performed to calculate opioid exposure by converting all sources of opioids to oral morphine milligram equivalents (MMEs). To estimate variation, an intraclass correlation was calculated from a multilevel generalized linear model adjusting for the a priori selected variables Injury Severity Score and prior opioid use. RESULTS: The centers enrolled 1,731 patients. The median opioid exposure among all sites was 45 MMEs per day, equivalent to 30 mg of oxycodone or 45 mg of hydrocodone per day. Variation in opioid exposure was identified both between and within trauma centers with the vast majority of variation (93%) occurring within trauma centers. Opioid exposure increased with injury severity, in male patients, and patients suffering penetrating trauma. CONCLUSION: The overall median opioid exposure was 45 MMEs per day. Despite significant differences in opioid exposure between trauma centers, the majority of variation was actually within centers. This suggests that efforts to minimize opioid exposure after injury should focus within trauma centers and not on high-level efforts to affect all trauma centers. LEVEL OF EVIDENCE: Epidemiological, level III.
BACKGROUND: Efforts to reduce opioid use in trauma patients are currently hampered by an incomplete understanding of the baseline opioid exposure and variation in United States. The purpose of this project was to obtain a global estimate of opioid exposure following injury and to quantify the variability of opioid exposure between and within United States trauma centers. STUDY DESIGN: Prospective observational study was performed to calculate opioid exposure by converting all sources of opioids to oral morphine milligram equivalents (MMEs). To estimate variation, an intraclass correlation was calculated from a multilevel generalized linear model adjusting for the a priori selected variables Injury Severity Score and prior opioid use. RESULTS: The centers enrolled 1,731 patients. The median opioid exposure among all sites was 45 MMEs per day, equivalent to 30 mg of oxycodone or 45 mg of hydrocodone per day. Variation in opioid exposure was identified both between and within trauma centers with the vast majority of variation (93%) occurring within trauma centers. Opioid exposure increased with injury severity, in male patients, and patients suffering penetrating trauma. CONCLUSION: The overall median opioid exposure was 45 MMEs per day. Despite significant differences in opioid exposure between trauma centers, the majority of variation was actually within centers. This suggests that efforts to minimize opioid exposure after injury should focus within trauma centers and not on high-level efforts to affect all trauma centers. LEVEL OF EVIDENCE: Epidemiological, level III.
Authors: Chad M Brummett; Jennifer F Waljee; Jenna Goesling; Stephanie Moser; Paul Lin; Michael J Englesbe; Amy S B Bohnert; Sachin Kheterpal; Brahmajee K Nallamothu Journal: JAMA Surg Date: 2017-06-21 Impact factor: 14.766
Authors: Duminda N Wijeysundera; Peter C Austin; Janet E Hux; W Scott Beattie; Andreas Laupacis Journal: J Clin Epidemiol Date: 2008-10-23 Impact factor: 6.437
Authors: Ryan Howard; Brian Fry; Vidhya Gunaseelan; Jay Lee; Jennifer Waljee; Chad Brummett; Darrell Campbell; Elizabeth Seese; Michael Englesbe; Joceline Vu Journal: JAMA Surg Date: 2019-01-16 Impact factor: 14.766
Authors: Joe Habbouche; Jay Lee; Rena Steiger; James M Dupree; Caitlin Khalsa; Michael Englesbe; Chad Brummett; Jennifer Waljee Journal: JAMA Surg Date: 2018-12-01 Impact factor: 14.766
Authors: Jonah J Stulberg; Willemijn L A Schäfer; Meagan L Shallcross; Bruce L Lambert; Reiping Huang; Jane L Holl; Karl Y Bilimoria; Julie K Johnson Journal: BMJ Open Date: 2019-06-03 Impact factor: 2.692
Authors: Carl A Beyer; Eduard Poltavskiy; Lauren E Walker; Warren Pettey; Ying Suo; Andrew Redd; Alex G Rittel; William H Kazanis; Jacob R Dunham; Lee A Zarzabal; W Cliff Rutter; Alan Sim; Jessica R Watrous; Jeffrey T Howard; Jud C Janak; Ian J Stewart; Adi Gundlapalli Journal: Ann Surg Date: 2021-12-01 Impact factor: 13.787
Authors: John A Harvin; Rondel Albarado; Van Thi Thanh Truong; Charles Green; Jon E Tyson; Claudia Pedroza; Charles E Wade; Lillian S Kao Journal: J Am Coll Surg Date: 2021-01-21 Impact factor: 6.113
Authors: Gabrielle E Hatton; Heather R Kregel; Claudia Pedroza; Thaddeus J Puzio; Sasha D Adams; Charles E Wade; Lillian S Kao; John A Harvin Journal: Ann Surg Date: 2021-10-01 Impact factor: 13.787
Authors: Sabina Schaffer; Dunya Bayat; Walter L Biffl; Jeffrey Smith; Kathryn B Schaffer; Tala H Dandan; Jiayan Wang; Deb Snyder; Chris Nalick; Imad S Dandan; Gail T Tominaga; Matthew R Castelo Journal: Trauma Surg Acute Care Open Date: 2022-03-24
Authors: Thaddeus J Puzio; James Klugh; Michael W Wandling; Charles Green; Julius Balogh; Samuel J Prater; Christopher T Stephens; Paulina B Sergot; Charles E Wade; Lillian S Kao; John A Harvin Journal: Trials Date: 2022-07-27 Impact factor: 2.728
Authors: Deepanjli Donthula; Christopher R Conner; Van Thi Thanh Truong; Charles Green; Chuantao Jiang; Michael W Wandling; Spogmai Komak; Todd F Huzar; Sasha D Adams; Daniel J Freet; David J Wainwright; Charles E Wade; Lillian S Kao; John A Harvin Journal: J Burn Care Res Date: 2021-11-24 Impact factor: 1.845